 BETHESDA, Md., Jan. 06, 2022 GLOBE NEWSWIRE -- Gain Therapeutics, Inc. Nasdaq: GANX Gain, a biotechnology company focused on identifying and optimizing allosteric binding sites that have never been targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that Chief Executive Officer Eric Richman, will participate in the H.C. Wainwright Bioconnect Conference and invites investors to participate via webcast. Please see additional details below: 